好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | H249 - Leadership Curriculum for Residents (Leadership University)

Thursday 04/18/24
08:00 AM - 09:00 AM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Leadership University)
Deborah Y. Bradshaw, MD, FAAN
Leadership, 好色先生, Research, and Methodology
Physicians are often handed leadership responsibilities without formal training, creating accidental leaders. The Gil Sl Ross Leadership Academy is a formal leadership training curriculum developed for neurology residents. It includes 36 longitudinal contact hours of training in conflict resolution, building emotional intelligence, addressing wellness, difficult conversation and other topics. This session reviews the purpose, structure, content, evaluation methods and impact of leadership training on our residents and faculty. Participants should learn the importance of leadership development for physicians and possible approaches to creating leadership curriculum.
1.00 CME credit

Program Evaluations

Event Timeline
08:00 AM - 09:00 AM MDT Speaker Leadership Curriculum for Residents
Deborah Y. Bradshaw, MD, FAAN, Corey A. McGraw, MD, Shahram Izadyar, MD, FAAN
Faculty Disclosures
Deborah Y. Bradshaw, MD, FAAN The institution of Dr. Bradshaw has received research support from Cytokinetics. Dr. Bradshaw has received publishing royalties from a publication relating to health care.
Corey A. McGraw, MD The institution of Dr. McGraw has received research support from Novartis. The institution of Dr. McGraw has received research support from F. Hoffmann - La Roche. The institution of Dr. McGraw has received research support from Genentech. The institution of Dr. McGraw has received research support from Neurona Therapeutics. The institution of Dr. McGraw has received research support from Instituto Grifols, S.A..
Shahram Izadyar, MD, FAAN The institution of Dr. Izadyar has received research support from Xenon Pharmaceuticals. An immediate family member of Dr. Izadyar has received publishing royalties from a publication relating to health care.